Nascent Biotech Inc.
company.status.inactiveCIK 1622057fmd_1AZJZ7DFF50W72WTD38FQRYGPTManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2013 to Jun 30, 2024, 43 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q1 FY2025
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- n/m
- Net income, 5 yearsFY2019 to FY2024
- n/m
Nascent Biotech Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2.2 million | -$2.2 million | 10-K 2024-07-01 · proof | |
| Net income | -$2.1 million | -$2.8 million | 10-K 2024-07-01 · proof | |
| Cash from operating activities | -$1.2 million | -$1.8 million | 10-K 2024-07-01 · proof | |
| Total assets | $552,120 | $255,002 | +116.5% | 10-K 2024-07-01 · proof |
| Total liabilities | $808,794 | $1.6 million | -47.9% | 10-K 2024-07-01 · proof |
| Cash and cash equivalents | $372,120 | $172,186 | +116.1% | 10-K 2024-07-01 · proof |
- What was Nascent Biotech Inc.'s operating income in fiscal 2024?
- Nascent Biotech Inc. reported operating income of -$2.2 million for fiscal 2024 (the year ended Mar 31, 2024), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Jul 1, 2024. SEC
- What was Nascent Biotech Inc.'s net income in fiscal 2024?
- Nascent Biotech Inc. reported net income of -$2.1 million for fiscal 2024 (the year ended Mar 31, 2024), against -$2.8 million the year before. Source: the 10-K filed with the SEC on Jul 1, 2024. SEC
- What was Nascent Biotech Inc.'s cash from operating activities in fiscal 2024?
- Nascent Biotech Inc. reported cash from operating activities of -$1.2 million for fiscal 2024 (the year ended Mar 31, 2024), against -$1.8 million the year before. Source: the 10-K filed with the SEC on Jul 1, 2024. SEC
- What are Nascent Biotech Inc.'s total assets?
- As of Mar 31, 2024, Nascent Biotech Inc. reported total assets of $552,120, against $255,002 a year earlier (+116.5%). Source: the 10-K filed with the SEC on Jul 1, 2024. SEC
- What are Nascent Biotech Inc.'s total liabilities?
- As of Mar 31, 2024, Nascent Biotech Inc. reported total liabilities of $808,794, against $1.6 million a year earlier (-47.9%). Source: the 10-K filed with the SEC on Jul 1, 2024. SEC
- What are Nascent Biotech Inc.'s cash and cash equivalents?
- As of Mar 31, 2024, Nascent Biotech Inc. reported cash and cash equivalents of $372,120, against $172,186 a year earlier (+116.1%). Source: the 10-K filed with the SEC on Jul 1, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1622057&period_type=annual&limit=5"Information only, not investment advice.